Pfizer, Lilly, Sanofi, Amgen And Others Implicated In Indian Clinical Trial Compensation Investigation; Are Ethics Committees To Blame?
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's Health Ministry is calling on multinational drug companies operating in India - including Pfizer Inc., Eli Lilly & Co., Amgen Inc., Bristol-Myers Squibb Co., Boehringer Ingelheim GMBH, Sanofi, and Quintiles Transnational Corp. - to explain why they have not provided compensation to the families of 26 patients who died during clinical trials in the last year. A recent health ministry investigation found that out of 671 cases of reported deaths allegedly involving clinical trials - and involving as many as 44 companies - only three were compensated, but companies suggest regulators should look to India's ethics committees for answers